Most-used single-cell platforms ranked by how many preprints say they used each
Single-cell platforms give each cell's RNA its own barcode, so one sequencing run can read thousands to millions of cells one by one. Chromium uses droplets, Rhapsody tiny wells and Evercode ordinary lab plates. Updated daily (as of Nov 16)
10x Chromium is the most-used single-cell platform.
10x Chromium had 91% of the uses in Jun–Nov 2026, down from 95% the year before. Parse Evercode is second with 6%.
| # | Platform | Last 6 months | Growth | Share | Total | By year |
|---|---|---|---|---|---|---|
| 1 | 1,044 preprints | −5% | 91%down from 95% | 3,635 93% | ||
| 2 | 69 preprints | +113% | 6%up from 3% | 178 5% | ||
| 3 | 31 preprints | Too few to compare | 3%up from 2% | 97 2% |
Last 6 months is Jun–Nov 2026. Growth compares it with Jun–Nov 2025, as a share of all preprints. Total counts every preprint since April 2025 that says it used the platform.
Top institutions for each platform
Stanford University70
University of California, San Francisco55
University of Pennsylvania51
Washington University in St. Louis42
University of Michigan42
University of California, Irvine6
University of California, San Francisco6
Stanford University6
University of North Carolina at Chapel Hill4
Icahn School of Medicine at Mount Sinai3
Heinrich Heine University Düsseldorf3
German Center for Neurodegenerative Diseases3
Fred Hutchinson Cancer Center2
University of Massachusetts Chan Medical School2
The University of Tokyo2
Counts every preprint since April 2025, by the corresponding author's institution.
Parse Evercode is growing fastest.
Up 113% in Jun–Nov 2026 vs the previous year as a share of all preprints. 10x Chromium was down 5%. BD Rhapsody has too few preprints to compare. All three together shrank 1%. Compare side by side: Chromium vs Evercode →
Chromium
Evercode
Rhapsody
The last bar is the quarter so far.
Latest preprints using single-cell sequencing
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.